The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease

por Schnur, Sabrina, Hans, Fabian, Dehne, Annika, Osti, Janina, Schneemann, Malte-Ole, Schneider, Marc, Hittinger, Marius
Publicado 2023

Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay

por Schnur, Sabrina, Wahl, Vanessa, Metz, Julia K., Gillmann, Jessica, Hans, Fabian, Rotermund, Katharina, Zäh, Ralf-Kilian, Brück, Dietmar A., Schneider, Marc, Hittinger, Marius
Publicado 2022